Who are Enamel Matrix Proteins's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Application of Enamel Matrix Derivatives.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/enamel-matrix-proteins.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Enamel Matrix Proteins — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enamel Matrix Proteins (Enamel Matrix Proteins) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Regenerative biologic / Periodontal regenerative material. Area: Dentistry / Periodontics.

marketed Regenerative biologic / Periodontal regenerative material Dentistry / Periodontics Biologic Live · refreshed every 30 min

Target snapshot

Enamel Matrix Proteins (Enamel Matrix Proteins) — University of Campinas, Brazil. Enamel matrix proteins promote periodontal tissue regeneration by stimulating the migration, proliferation, and differentiation of periodontal ligament cells and osteoblasts.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Enamel Matrix Proteins TARGET	Enamel Matrix Proteins	University of Campinas, Brazil	marketed	Regenerative biologic / Periodontal regenerative material
Application of Enamel Matrix Derivatives	Application of Enamel Matrix Derivatives	Universidad Complutense de Madrid	marketed	Regenerative biologic / Periodontal regenerative material	Amelogenins and associated enamel matrix proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Regenerative biologic / Periodontal regenerative material class)

Universidad Complutense de Madrid · 1 drug in this class
University of Campinas, Brazil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Enamel Matrix Proteins — Competitive Intelligence Brief. https://druglandscape.com/ci/enamel-matrix-proteins. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing